<--- Back to Details
First PageDocument Content
Morphinans / Euphoriants / Drug rehabilitation / Ethers / Phenols / Buprenorphine / Methadone / Opioid / Drug Addiction Treatment Act / Chemistry / Organic chemistry / Medicine
Date: 2015-05-27 12:16:52
Morphinans
Euphoriants
Drug rehabilitation
Ethers
Phenols
Buprenorphine
Methadone
Opioid
Drug Addiction Treatment Act
Chemistry
Organic chemistry
Medicine

The Recovery Enhancement for Addiction Treatment Act (TREAT Act) Senator Edward J. Markey (D-Mass.) Overdoses from opioids, including prescription pain relievers and heroin, have increased dramatically in the United Stat

Add to Reading List

Source URL: www.markey.senate.gov

Download Document from Source Website

File Size: 102,60 KB

Share Document on Facebook

Similar Documents

Microsoft Word - VLD Packet.FINAL

Microsoft Word - VLD Packet.FINAL

DocID: 1rubZ - View Document

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

DocID: 1rtjz - View Document

TITAN	PHARMACEUTICALS	  CORPORATE	PRESENTATION	Ÿ	SUNIL	BHONSLE	Ÿ	JUNE	2016 ©	2016	TITAN	PHARMACEUTICALS	INC.	Ÿ	NASDAQ:TTNP

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

DocID: 1rsmr - View Document

  “Hokus-Pokus Palliative Care” Case Report Gabriela Popescu, MD, M.Sc. Palliative Care, FMH Internal Medicine Tumor Zentrum and Hirslanden Klinik Aarau

“Hokus-Pokus Palliative Care” Case Report Gabriela Popescu, MD, M.Sc. Palliative Care, FMH Internal Medicine Tumor Zentrum and Hirslanden Klinik Aarau

DocID: 1rsfZ - View Document

Sunil Bhonsle  Mar 2015 Corporate Presentation

Sunil Bhonsle Mar 2015 Corporate Presentation

DocID: 1rrwl - View Document